lobbying_activities: 2067776

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2067776	0d03fdf2-7eae-4e56-99c7-952aa5b720d9	Q4	OREGON HEALTH & SCIENCE UNIVERSITY	30291	OREGON HEALTH & SCIENCE UNIVERSITY	2017	fourth_quarter	BUD	FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (HR 5054/ S.2956); FY2017 funding for Zika: "Zika Response Appropriations Act, 2016" (HR5243), Division B in "Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; HR 244, Consolidated Appropriations Act 2017 (P.L. 115-31); health and science related funding issues. HR 3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; HJ Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (PL 115-90); HR 1370, Further Additional Continuing Appropriations Act, 2018 (PL 115-96); health and science related funding issues.	HOUSE OF REPRESENTATIVES,SENATE		80000	0	0	2018-01-18T13:30:17.057000-05:00